Casgevy, Lyfgenia Medicare Add-On Payments In Sickle Cell Are Not Conditioned On Outcomes-Based Contracting

 
• By Cathy Kelly
Hospitals Still Face High Medical Costs Associated With the Gene Therapies Treatment. • Source: Shutterstock

More from Cell & Gene Therapies

More from Advanced Technologies